Loading...
Loading...
Among the 7 tracked institutional investors we monitor, 430 (TERNS PHARMACEUTICALS INC) is held with a combined value of $1.07B across 21,529,461 shares. The largest holder is BlackRock, Inc. with a position worth $504.51M (0.01% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 3 funds increased their holdings. 3 funds reduced their position.
Total Institutional Value
$1.07B
Total Shares Held
21,529,461
Institutional Holders
7
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $504.51M | 0.01% | +16.8% |
| 2 | VANGUARD GROUP INC | $223.17M | 0.00% | New |
| 3 | CITADEL ADVISORS LLC | $197.56M | 0.03% | +10.2% |
| 4 | STATE STREET CORP | $112.80M | 0.00% | +20.5% |
| 5 | FMR LLC | $19.80M | 0.00% | -63.4% |
| 6 | RENAISSANCE TECHNOLOGIES LLC | $8.91M | 0.01% | -63.8% |
| 7 | Point72 Asset Management, L.P. | $226.70K | 0.00% | -99.3% |
As of the latest SEC 13F filings, BlackRock, Inc. is the largest institutional holder of 430 with a position worth $504.51M, representing 0.01% of their portfolio. In total, 7 institutional investors hold 430 with a combined value of $1.07B.
In the most recent quarter, 1 fund opened a new position in 430. Additionally, 3 increased their holdings and 3 reduced their positions.
Institutional investors hold $1.07B worth of 430 stock across 7 positions. The largest institutional holder is BlackRock, Inc. with $504.51M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For 430, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their 430 positions.